[1]
“Current strategies for adoptive immunotherapy for cancer: ”Off-the-shelf” immune cells”, Biomed. Res. Ther., vol. 7, no. 12, pp. 4170–4189, Dec. 2020, doi: 10.15419/bmrat.v7i12.655.